A selection of attractive stocks for troubled times
Professional investor Alec Cutler of the Orbis Global Balanced Fund picks two well-placed stocks and a key investment theme to buy now.


Russia’s invasion of Ukraine has shocked and appalled us and the rest of the world. It has also left investors with a whole Pandora’s box of unanswered questions to unpack in the weeks and months to come.
In times like this, you can still build a portfolio of attractive individual stocks even if you don’t have all the big picture answers. When markets are as rattled by extreme events as they have been recently, there are always gaps between price and fundamentals that can present opportunities for stock selection.
Burford Capital: pioneering a profitable niche
In uncertain times, owning shares of idiosyncratic businesses can provide valuable diversification away from geopolitical and macroeconomic turbulence. Burford Capital (LSE: BUR) is a great example. It pioneered the niche of litigation finance. Just like a stockpicker, it excels at picking litigation opportunities to bankroll. If you are involved in a major lawsuit and need money to keep the fight going, Burford will provide it. In exchange, it is entitled to a share of the winnings if you prevail in court.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
While Burford doesn’t always back the winning party, it has an extremely good record when it comes to assessing the merits of cases and the risk-reward proposition. As a result of this unique expertise, it is one of the very few companies that is good at litigation finance and its return on invested capital is astronomical. We expect the share price to reward us over our long-term investment horizon.
Kinder Morgan: a natural-gas toll collector
The world was already facing an energy crisis well before Russia’s invasion of Ukraine. Since then, the need for energy security has only become more urgent. This bodes particularly well for natural gas, which investors are starting to realise is critical to the energy transition.
As the operator of the largest natural-gas pipeline network in the US, Kinder Morgan (NYSE: KMI) is basically a toll-collector. About 90% of its business is in long-term take-or-pay contracts with investment-grade customers such as electric utilities.
Co-founder Richard Kinder, who set up the business in 1997, continues to serve as chairman. He is also the largest shareholder with an 11% stake in the company. As further evidence of his shareholder orientation, Kinder is paid just $1 in annual salary and forbids the use of corporate jets. At the current share price, the company offers a generous and sustainable 6.5% dividend yield.
Investing in defence
It’s impossible to know how current events in Ukraine will play out. We would all love to live in a world that did not require defence spending. However, Russia’s recent actions have proved one thing: defence spending is essential to protect our societies.
In recent years, the lack of attention that this sector has received from analysts and fund managers has been remarkable. At a recent virtual presentation we were one of only two attendees. This may now change.
Defence companies such as BAE Systems (LSE: BA) in the UK, Saab (Stockholm: SAABB) in Sweden, and Rheinmetall (Frankfurt: RHM) in Germany should be clear beneficiaries of greater defence spending. At the same time, investors may come to realise that these companies perform an incredibly valuable social role in protecting Europe.
• Listen to Alec discuss these and other stock picks with Merryn on the MoneyWeek Podcast
Sign up for MoneyWeek's newsletters
Get the latest financial news, insights and expert analysis from our award-winning MoneyWeek team, to help you understand what really matters when it comes to your finances.
Alec Cutler joined Orbis Investment in 2004. Based in Bermuda, he leads the multi-asset team, is one of the portfolio managers for the Orbis Global Balanced Strategy, and has overall responsibility for the strategy. He previously worked for ten years at Brandywine Asset Management LLC managing the Relative Value strategy, co-managing the Large Cap Value area and co-managing the firm as a member of the executive committee.
Alec holds a Bachelor of Science degree in naval architecture from the United States Naval Academy, a Master of Business Administration from the Wharton School of the University of Pennsylvania, and is a Chartered Financial Analyst.
-
Review: Trasierra – a yoga retreat in the Spanish hills
Flora Connell joins a yoga retreat at Trasierra, in the Sierra Morena mountains north of Seville
By Flora Connell Published
-
How much should I have in emergency savings?
When your boiler breaks or your car won’t start, you can find yourself paying a hefty bill. How much should you have in emergency savings to cover unexpected costs?
By Katie Williams Published
-
Cash in on the growth prospects of Europe's companies
Opinion Marcel Stötzel, co-portfolio manager of the Fidelity European Trust, selects three stocks
By Marcel Stotzel Published
-
Why CEOs deserve a pay rise
Opinion The CEOs of big companies often come under fire for being grossly overpaid. But the truth, as per some economists, is the opposite. Do they merit a pay rise?
By Stuart Watkins Published
-
Rolls-Royce stock jumps 15% – could it climb further?
Aircraft-engine group Rolls-Royce’s CEO has been hailed as a hero for spearheading the firm’s recovery. And the future looks bright, says Matthew Partridge
By Dr Matthew Partridge Published
-
The power of private markets
Interview Helen Steers, co-manager of the Pantheon International investment trust, tells MoneyWeek about the vast array of compelling opportunities in private equity
By Andrew Van Sickle Published
-
Vertex Pharmaceuticals is an uncommon opportunity in rare diseases
Vertex Pharmaceuticals operates in a profitable subsector and is poised for further success
By Dr Mike Tubbs Published
-
Global investors have overlooked these top tips in emerging markets
Opinion Chris Tennant, co-portfolio manager of Fidelity Emerging Markets, picks three attractive companies in emerging markets
By Chris Tennant Published
-
King Coal has not been dethroned yet — should you buy?
The demand for coal is only growing, yet investors don’t seem to want to take advantage of the opportunity, says Rupert Hargreaves
By Rupert Hargreaves Published
-
It’s time to start buying Europe again, says Merryn Somerset Webb
Opinion Europe's stocks are cheap and the economic backdrop is starting to look cheerier, says Merryn Somerset Webb
By Merryn Somerset Webb Published